Yan‐Fang Xing

708 total citations
32 papers, 538 citations indexed

About

Yan‐Fang Xing is a scholar working on Immunology, Hepatology and Oncology. According to data from OpenAlex, Yan‐Fang Xing has authored 32 papers receiving a total of 538 indexed citations (citations by other indexed papers that have themselves been cited), including 10 papers in Immunology, 9 papers in Hepatology and 7 papers in Oncology. Recurrent topics in Yan‐Fang Xing's work include Immune cells in cancer (9 papers), Hepatocellular Carcinoma Treatment and Prognosis (6 papers) and Inflammatory Biomarkers in Disease Prognosis (6 papers). Yan‐Fang Xing is often cited by papers focused on Immune cells in cancer (9 papers), Hepatocellular Carcinoma Treatment and Prognosis (6 papers) and Inflammatory Biomarkers in Disease Prognosis (6 papers). Yan‐Fang Xing collaborates with scholars based in China and Hong Kong. Yan‐Fang Xing's co-authors include Xing Li, Xiaokun Ma, Dan‐Yun Ruan, Qu Lin, Xiangyuan Wu, Zhan‐Hong Chen, Jie Chen, Dong‐Hao Wu, Jing‐Yun Wen and Min Dong and has published in prestigious journals such as Journal of Clinical Oncology, The Journal of Immunology and Kidney International.

In The Last Decade

Yan‐Fang Xing

30 papers receiving 531 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Yan‐Fang Xing China 12 213 168 160 127 96 32 538
Jianhua Li China 13 120 0.6× 79 0.5× 107 0.7× 112 0.9× 108 1.1× 54 561
Yasuhide Motoyoshi Japan 14 135 0.6× 134 0.8× 279 1.7× 316 2.5× 49 0.5× 27 625
Yimin Mao China 16 138 0.6× 61 0.4× 180 1.1× 196 1.5× 79 0.8× 52 729
Simon Johannes Gairing Germany 13 173 0.8× 70 0.4× 304 1.9× 310 2.4× 119 1.2× 45 714
George Khoudari United States 10 202 0.9× 43 0.3× 165 1.0× 55 0.4× 98 1.0× 34 581
Mohamed Ebrahim Egypt 13 127 0.6× 47 0.3× 57 0.4× 54 0.4× 60 0.6× 56 476
Nirmala Parajuli United States 13 127 0.6× 168 1.0× 121 0.8× 76 0.6× 32 0.3× 25 638
Natalia Khalaf United States 13 341 1.6× 35 0.2× 134 0.8× 105 0.8× 154 1.6× 38 704
Jota Watanabe Japan 12 134 0.6× 68 0.4× 63 0.4× 92 0.7× 38 0.4× 35 485

Countries citing papers authored by Yan‐Fang Xing

Since Specialization
Citations

This map shows the geographic impact of Yan‐Fang Xing's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Yan‐Fang Xing with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Yan‐Fang Xing more than expected).

Fields of papers citing papers by Yan‐Fang Xing

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Yan‐Fang Xing. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Yan‐Fang Xing. The network helps show where Yan‐Fang Xing may publish in the future.

Co-authorship network of co-authors of Yan‐Fang Xing

This figure shows the co-authorship network connecting the top 25 collaborators of Yan‐Fang Xing. A scholar is included among the top collaborators of Yan‐Fang Xing based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Yan‐Fang Xing. Yan‐Fang Xing is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Xing, Yan‐Fang, Xiang-yuan Wu, Zhaohui Shi, et al.. (2025). Thymic Microenvironment Remodeling in Cancer Cachexia as a Determinant of Checkpoint Inhibitor Efficacy and Toxicity. Journal of Cachexia Sarcopenia and Muscle. 16(4). e13874–e13874. 2 indexed citations
2.
Li, Xing, Jie Chen, Yongjian Chen, et al.. (2021). Dexamethasone and lactoferrin induced PMN-MDSCs relieved inflammatory adverse events of anti-cancer therapy without tumor promotion. Communications Biology. 4(1). 252–252. 3 indexed citations
3.
Xing, Yan‐Fang, et al.. (2021). Expansion of Monocytic Myeloid-Derived Suppressor Cells in Patients Under Hemodialysis Might Lead to Cardiovascular and Cerebrovascular Events. Frontiers in Immunology. 11. 577253–577253. 8 indexed citations
4.
Xing, Yan‐Fang, Jianhua Ren, Yongjian Chen, et al.. (2021). Mandatory Mask-Wearing and Hand Hygiene Associated With Decreased Infectious Diseases Among Patients Undergoing Regular Hemodialysis: A Historical-Control Study. Frontiers in Public Health. 9. 678738–678738. 5 indexed citations
5.
Chen, Jie, Yongjian Chen, Nan Jiang, et al.. (2021). Neutrophil-to-Apolipoprotein A1 Ratio Predicted Overall Survival in Hepatocellular Carcinoma Receiving Transarterial Chemoembolization. The Oncologist. 26(8). e1434–e1444. 14 indexed citations
6.
Deng, Xiaohui, Xing Li, Yingjiao Cao, et al.. (2020). Expansion of Group 2 Innate Lymphoid Cells in Patients with End-Stage Renal Disease and Their Clinical Significance. The Journal of Immunology. 205(1). 36–44. 8 indexed citations
7.
Wu, Meng–Huang, et al.. (2019). <p>Pretransplant metabolic syndrome and its components predict post-transplantation diabetes mellitus in Chinese patients receiving a first renal transplant</p>. Therapeutics and Clinical Risk Management. Volume 15. 497–503. 7 indexed citations
8.
9.
Feng, Ding-Yun, Yuqi Zhou, Yan‐Fang Xing, et al.. (2018). Selection of glucocorticoid-sensitive patients in interstitial lung disease secondary to connective tissue diseases population by radiomics. Therapeutics and Clinical Risk Management. Volume 14. 1975–1986. 13 indexed citations
10.
Chen, Xiangwei, Zhan‐Hong Chen, Xiu−Yan Huang, et al.. (2017). A multidisciplinary team approach for nutritional interventions conducted by specialist nurses in patients with advanced colorectal cancer undergoing chemotherapy. Medicine. 96(26). e7373–e7373. 18 indexed citations
11.
Xing, Yan‐Fang, et al.. (2017). Expansion of polymorphonuclear myeloid-derived suppressor cells in patients with end-stage renal disease may lead to infectious complications. Kidney International. 91(5). 1236–1242. 19 indexed citations
12.
Li, Xing, Xiang Zhong, Zhan‐Hong Chen, et al.. (2016). Efficacy of Prophylactic Entecavir for Hepatitis B Virus-Related Hepatocellular Carcinoma Receiving Transcatheter Arterial Chemoembolization. Asian Pacific Journal of Cancer Prevention. 16(18). 8665–8670. 10 indexed citations
13.
14.
Li, Xing, Xiang Zhong, Zhan‐Hong Chen, et al.. (2014). Hepatitis B Virus DNA Negativity Acts as a Favorable Prognostic Factor in Hepatocellular Carcinoma Patients. Asian Pacific Journal of Cancer Prevention. 15(22). 9635–9641. 11 indexed citations
15.
Wu, Dong‐Hao, Changchang Jia, Jie Chen, et al.. (2014). Autophagic LC3B overexpression correlates with malignant progression and predicts a poor prognosis in hepatocellular carcinoma. Tumor Biology. 35(12). 12225–12233. 77 indexed citations
16.
Li, Xing, Zhan‐Hong Chen, Xiaokun Ma, et al.. (2014). Neutrophil-to-lymphocyte ratio acts as a prognostic factor for patients with advanced hepatocellular carcinoma. Tumor Biology. 35(11). 11057–11063. 35 indexed citations
17.
Li, Xing, Zhan‐Hong Chen, Yan‐Fang Xing, et al.. (2014). Platelet-to-lymphocyte ratio acts as a prognostic factor for patients with advanced hepatocellular carcinoma. Tumor Biology. 36(4). 2263–2269. 91 indexed citations
18.
Peng, Hui, Yan‐Fang Xing, Zengchun Ye, et al.. (2013). High glucose induces activation of the local renin-angiotensin system in glomerular endothelial cells. Molecular Medicine Reports. 9(2). 450–456. 20 indexed citations
19.
Wu, Xiangyuan, Xing Li, Zhan‐Hong Chen, et al.. (2012). An optimized antiviral modification strategy for prevention of hepatitis B reactivation in patients undergoing prophylactic lamivudine and chemotherapy: a pilot study. Tumor Biology. 34(2). 909–918. 7 indexed citations
20.
Li, Xing, Yan‐Fang Xing, Qu Lin, et al.. (2012). The treatment of severe hepatitis B virus reactivation after chemotherapy. Nature Reviews Clinical Oncology. 9(6). 350–350. 3 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Jianhua Li Breakdown of academic impact, for papers by Yasuhide Motoyoshi Breakdown of academic impact, for papers by Yimin Mao Breakdown of academic impact, for papers by Simon Johannes Gairing Breakdown of academic impact, for papers by George Khoudari Breakdown of academic impact, for papers by Mohamed Ebrahim Breakdown of academic impact, for papers by Nirmala Parajuli Breakdown of academic impact, for papers by Natalia Khalaf Breakdown of academic impact, for papers by Jota Watanabe
Rankless by CCL
2026